Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2017 December;58(6) > The Journal of Cardiovascular Surgery 2017 December;58(6):870-4

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

THE JOURNAL OF CARDIOVASCULAR SURGERY

A Journal on Cardiac, Vascular and Thoracic Surgery


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,179


eTOC

 

REVIEW  RECENT DEVELOPMENTS IN JUXTARENAL AND AORTO-ILIAC INTERVENTIONS


The Journal of Cardiovascular Surgery 2017 December;58(6):870-4

DOI: 10.23736/S0021-9509.17.10069-8

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Endovascular treatment of mycotic aortic aneurysms: a paradigm shift

Karl SÖRELIUS , Kevin MANI, Martin BJÖRCK, Anders WANHAINEN

Section of Vascular Surgery, Department of Surgical Sciences, Uppsala, Sweden


PDF  


Treatment of mycotic aortic aneurysms (MAAs) composes a particularly difficult challenge. Open repair has been considered the gold standard, despite lack of evidence supporting its superiority compared with the emerging alternative endovascular aortic repair (EVAR). This review discusses the pros and cons of EVAR for MAAs by dissecting the three largest publications on MAAs, and concludes that there has been a paradigm shift in treatment of MAAs for the benefit of EVAR.


KEY WORDS: Aortic aneurysm - Mycoses - Surgery - Endovascular procedures

top of page

Publication History

Issue published online: September 14, 2017
Article first published online: June 19, 2017
Manuscript accepted: June 16, 2017
Manuscript received: June 12, 2017

Cite this article as

Sörelius K, Mani K, Björck M, Wanhainen A. Endovascular treatment of mycotic aortic aneurysms: a paradigm shift. J Cardiovasc Surg 2017;58:870-4. DOI: 10.23736/S0021-9509.17.10069-8

Corresponding author e-mail

karlsorelius@hotmail.com